Download PDF
Thromb Haemost 2017; 117(02): 357-370
DOI: 10.1160/TH16-07-0524
Endothelium and Angiogenesis
Schattauer GmbH

mCRP triggers angiogenesis by inducing F3 transcription and TF signalling in microvascular endothelial cells

Esther Peña
1   Cardiovascular Research Center (CSIC-ICCC), Institut Investigacions Biomèdiques Sant Pau (IIB-Sant Pau)
,
Raquel de la Torre
1   Cardiovascular Research Center (CSIC-ICCC), Institut Investigacions Biomèdiques Sant Pau (IIB-Sant Pau)
,
Gemma Arderiu
1   Cardiovascular Research Center (CSIC-ICCC), Institut Investigacions Biomèdiques Sant Pau (IIB-Sant Pau)
,
Mark Slevin
2   School of Healthcare Science, Manchester Metropolitan University, Manchester, UK
,
Lina Badimon
1   Cardiovascular Research Center (CSIC-ICCC), Institut Investigacions Biomèdiques Sant Pau (IIB-Sant Pau)
3   Cardiovascular Research Chair-Foundation Jesus Serra, UAB, Barcelona, Spain
› Author Affiliations
Financial support: This work was supported by Spanish Ministry of Science Plan Estatal I+D+I 2013–2016 [SAF2013–42962-R to LB] cofunded by Fondo Europeo de Desarrollo Regional (FEDER-“Una manera de hacer Europa”), Red de Terapia Celular [RD/12/0019/0026 to LB] and Red Investigación Cardiovascular [RD/12/00420027 to LB] (CPII13/00012, PI12/02332 to GA) from Instituto Salud Carlos III (ISCIII), Fundación de Investigación Cardiovascular and Fundación Jesus Serra. GA is a Miguel Servet investigator from the Instituto de Salud Carlos III.
Further Information

Publication History

Received:11 July 2016

Accepted after major revision:16 October 2016

Publication Date:
01 December 2017 (online)

   Permissions and Reprints

Summary

Inflammation contributes to vascular disease progression. However, the role of circulating inflammatory molecules on microvascular endothelial cell (mECs) is not fully elucidated. The aim of this study was to investigate the effects of the short pentraxin CRP on microvascular endothelial cell angiogenic function. Subcutaneously implanted collagen plugs seeded with human mECs exposed to monomeric CRP (mCRP) in mice showed formation of an extended network of microvessels both in the plug and the overlying skin tissue, while mECs exposure to pentameric native CRP (nCRP) induced a much milder effect. To understand the mechanisms behind this angiogenic effects, mECs were exposed to both CRP forms and cell migration, wound repair and tube-like formation were investigated. nCRP effects were moderate and of slow-onset whereas mCRP induced rapid, and highly significant effects. We investigated how circulating nCRP is transformed into mCRP by confocal microscopy and western blot. nCRP is transformed into mCRP on the mECs membranes in a time dependent fashion. This transformation is specific and in part receptor dependent, and the formed mCRP triggers F3 gene transcription and TF-protein expression in mECs to induce angiogenesis. F3-silenced mECs are unable to form angiotubes. In agreement, mCRP induced upregulation of the TF signalling pathway in mECs with downstream phosphorylation of AKT and activation of the transcription factor ETS1 leading to increased CCL2 release. The circulating pentraxin nCRP with little pro-angiogenic effect when dissociated into mCRP on the surface of mECs is able to trigger potent proangiogenic effects by inducing F3-gene upregulation and TF signalling.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Tissue factor - angiogenesis - vessel wall remodelling - C-reactive protein - endothelial cells

 

  • References

  • 1 Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem 2004; 279: 48487-48490.
    CrossrefPubMedSearch in Google Scholar
  • 2 Vilahur G, Badimon L. Biological actions of pentraxins. Vascular Pharmacol 2015; 73: 38-44.
    CrossrefPubMedSearch in Google Scholar
  • 3 Braunwald E. Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. Eur Heart J 2012; 33: 430-432.
    CrossrefPubMedSearch in Google Scholar
  • 4 Diehl EE, Haines GK, 3rd Radosevich JA. et al. Immunohistochemical localisation of modified C-reactive protein antigen in normal vascular tissue.. Am J Med Sci 2000; 319: 79-83.
    CrossrefPubMedSearch in Google Scholar
  • 5 Rees RF, Gewurz H, Siegel JN. et al. Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle.. Clin Immunol Imunopathol 1988; 48: 95-107.
    PubMedSearch in Google Scholar
  • 6 Krupinski J, Turu MM, Martinez-Gonzalez J. et al. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques.. Stroke 2006; 37: 1200-1204.
    CrossrefPubMedSearch in Google Scholar
  • 7 Eisenhardt SU, Habersberger J, Murphy A. et al. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.. Circ Res 2009; 105: 128-137.
    CrossrefPubMedSearch in Google Scholar
  • 8 Yasojima K, Schwab C, McGeer EG. et al. Generation of C-reactive protein and complement components in atherosclerotic plaques.. Am J Pathol 2001; 158: 1039-1051.
    CrossrefPubMedSearch in Google Scholar
  • 9 Turu MM, Slevin M, Matou S. et al. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression.. BMC Cell Biol 2008; 09: 47.
    CrossrefPubMedSearch in Google Scholar
  • 10 Slevin M, Matou-Nasri S, Turu M. et al. Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro.. Brain Pathol 2010; 20: 151-165.
    CrossrefPubMedSearch in Google Scholar
  • 11 Carmeliet P. Angiogenesis in health and disease. Nature Med 2003; 09: 653-660.
    CrossrefPubMedSearch in Google Scholar
  • 12 Juan-Babot JO, Martinez-Gonzalez J, Berrozpe M. et al. [Neovascularisation in human coronary arteries with lesions of different severity].. Revista Espan Cardiol 2003; 56: 978-986.
    PubMedSearch in Google Scholar
  • 13 Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004; 44: 2293-2300.
    CrossrefPubMedSearch in Google Scholar
  • 14 Arderiu G, Pena E, Aledo R. et al. Tissue factor regulates microvessel formation and stabilisation by induction of chaemokine (C-C motif) ligand 2 expression.. Arterioscl Thromb Vasc Biol 2011; 31: 2607-2615.
    CrossrefPubMedSearch in Google Scholar
  • 15 Toschi V, Gallo R, Lettino M. et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.. Circulation 1997; 95: 594-599.
    CrossrefPubMedSearch in Google Scholar
  • 16 Badimon JJ, Lettino M, Toschi V. et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.. Circulation 1999; 99: 1780-1787.
    CrossrefPubMedSearch in Google Scholar
  • 17 Wilcox JN, Smith KM, Schwartz SM. et al. Localisation of tissue factor in the normal vessel wall and in the atherosclerotic plaque.. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
    CrossrefPubMedSearch in Google Scholar
  • 18 Arderiu G, Pena E, Aledo R. et al. Ets-1 transcription is required in tissue factor driven microvessel formation and stabilisation.. Angiogenesis 2012; 15: 657-669.
    CrossrefPubMedSearch in Google Scholar
  • 19 Molins B, Pena E, Vilahur G. et al. C-reactive protein isoforms differ in their effects on thrombus growth.. Arterioscl Thromb Vasc Biol 2008; 28: 2239-2246.
    CrossrefPubMedSearch in Google Scholar
  • 20 Molins B, Pena E, de la Torre R. et al. Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow.. Cardiovasc Res 2011; 92: 328-337.
    CrossrefPubMedSearch in Google Scholar
  • 21 de la Torre R, Pena E, Vilahur G. et al. Monomerisation of C-reactive protein requires glycoprotein IIb-IIIa activation: pentraxins and platelet deposition.. J Thromb Haemost 2013; 11: 2048-2058.
    CrossrefPubMedSearch in Google Scholar
  • 22 Kresl JJ, Potempa LA, Anderson BE. Conversion of native oligomeric to a modified monomeric form of human C-reactive protein. Int J Biochem Cell Biol 1998; 30: 1415-1426.
    CrossrefPubMedSearch in Google Scholar
  • 23 Ades EW, Candal FJ, Swerlick RA. et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line.. J Invest Dermatol 1992; 99: 683-690.
    CrossrefPubMedSearch in Google Scholar
  • 24 Arderiu G, Pena E, Aledo R. et al. Tissue factor-Akt signalling triggers microvessel formation.. J Thromb Haemost 2012; 10: 1895-1905.
    CrossrefPubMedSearch in Google Scholar
  • 25 Pena E, Arderiu G, Badimon L. Subcellular localisation of tissue factor and human coronary artery smooth muscle cell migration. J Thromb Haemost 2012; 10: 2373-2382.
    CrossrefPubMedSearch in Google Scholar
  • 26 Ferrer-Lorente R, Bejar MT, Tous M. et al. Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function.. Diabetologia 2014; 57: 246-256.
    CrossrefPubMedSearch in Google Scholar
  • 27 Lugano R, Pena E, Badimon L. et al. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.. J Thromb Haemost 2012; 10: 2158-2167.
    CrossrefPubMedSearch in Google Scholar
  • 28 Etienne-Manneville S, Hall A. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 2001; 106: 489-498.
    CrossrefPubMedSearch in Google Scholar
  • 29 Hall A. Rho GTPases and the control of cell behavior. Biochem Soc Transact 2005; 33: 891-895.
    CrossrefPubMedSearch in Google Scholar
  • 30 Carrio M, Arderiu G, Myers C. et al. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model.. Cancer Res 2005; 65: 7177-7185.
    CrossrefPubMedSearch in Google Scholar
  • 31 Molins B, Pena E, Padro T. et al. Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin.. Arterioscl Thromb Vasc Biol 2010; 30: 1246-1252.
    CrossrefPubMedSearch in Google Scholar
  • 32 Camino-Lopez S, Llorente-Cortes V, Sendra J. et al. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.. Cardiovasc Res 2007; 73: 208-216.
    CrossrefPubMedSearch in Google Scholar
  • 33 Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
    CrossrefPubMedSearch in Google Scholar
  • 34 Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005; 04: 3-8.
    CrossrefPubMedSearch in Google Scholar
  • 35 Szekanecz Z, Koch AE. Mechanisms of Disease: angiogenesis in inflammatory diseases. Nature Clin Pract Rheumatol 2007; 03: 635-643.
    CrossrefPubMedSearch in Google Scholar
  • 36 Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med 2000; 06: 389-395.
    CrossrefPubMedSearch in Google Scholar
  • 37 Ridker PM, Danielson E, Fonseca FA. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.. N Engl J Med 2008; 359: 2195-2207.
    CrossrefPubMedSearch in Google Scholar
  • 38 Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
    CrossrefPubMedSearch in Google Scholar
  • 39 Ji SR, Ma L, Bai CJ. et al. Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains.. FASEB J 2009; 23: 1806-1816.
    CrossrefPubMedSearch in Google Scholar
  • 40 Khreiss T, Jozsef L, Potempa LA. et al. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells.. Circulation 2004; 109: 2016-2022.
    CrossrefPubMedSearch in Google Scholar
  • 41 Devaraj S, Du Clos TW, Jialal I. Binding and internalisation of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscl Thromb Vasc Biol 2005; 25: 1359-1363.
    CrossrefPubMedSearch in Google Scholar
  • 42 Pasceri V, Cheng JS, Willerson JT. et al. Modulation of C-reactive protein-mediated monocyte chaemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.. Circulation 2001; 103: 2531-2534.
    CrossrefPubMedSearch in Google Scholar
  • 43 Verma S, Li SH, Badiwala MV. et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.. Circulation 2002; 105: 1890-1896.
    CrossrefPubMedSearch in Google Scholar
  • 44 Wang HW, Sui SF. Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins. Biochem Biophys Res Commun 2001; 288: 75-79.
    CrossrefPubMedSearch in Google Scholar
  • 45 Bharadwaj D, Stein MP, Volzer M. et al. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.. The J Exp Med 1999; 190: 585-590.
    PubMedSearch in Google Scholar
  • 46 Escribano-Burgos M, Lopez-Farre A, del Mar Gonzalez M. et al. Effect of C-reactive protein on Fcgamma receptor II in cultured bovine endothelial cells.. Clin Sci 2005; 108: 85-91.
    CrossrefPubMedSearch in Google Scholar
  • 47 Hein TW, Qamirani E, Ren Y. et al. Selective activation of lectin-like oxidized low-density lipoprotein receptor-1 mediates C-reactive protein-evoked endothelial vasodilator dysfunction in coronary arterioles.. Circ Res 2014; 114: 92-100.
    CrossrefPubMedSearch in Google Scholar
  • 48 Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscl Thromb Vasc Biol 1995; 15: 612-621.
    CrossrefPubMedSearch in Google Scholar
  • 49 Versteeg HH, Peppelenbosch MP, Spek CA. Tissue factor signal transduction in angiogenesis. Carcinogenesis 2003; 24: 1009-1013.
    CrossrefPubMedSearch in Google Scholar
  • 50 Arderiu G, Espinosa S, Pena E. et al. Monocyte-secreted Wnt5a interacts with FZD5 in microvascular endothelial cells and induces angiogenesis through tissue factor signalling.. J Mol Cell Biol 2014; 06: 380-393.
    CrossrefPubMedSearch in Google Scholar
  • 51 Wu J, Stevenson MJ, Brown JM. et al. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.. Arterioscl Thromb Vasc Biol 2008; 28: 698-704.
    CrossrefPubMedSearch in Google Scholar
  • 52 Cirillo P, Golino P, Calabro P. et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation.. Cardiovasc Res 2005; 68: 47-55.
    CrossrefPubMedSearch in Google Scholar